Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Hebeda Dave — Sagent Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Hebeda Dave

Hebeda Dave

Vice President, Finance at Sagent Pharmaceuticals, Inc. · on record since Apr 19, 2011

Insider trading activity of Hebeda Dave

Transactions on record: 1; since Feb 24, 2012

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 24, 2012

Figures computed from official regulatory filings — methodology.

Companies where Hebeda Dave has traded

Sagent Pharmaceuticals, Inc.1 tx · Feb 24, 2012

Track record of Hebeda Dave

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hebeda Dave

Co-insiders of Hebeda Dave

Behrens Mary TaylorSagent Pharmaceuticals, Inc.
BRYNJELSEN SEANSagent Pharmaceuticals, Inc.
BULLOCK DONALD RSagent Pharmaceuticals, Inc.
China Harvest Fund II, LPSagent Pharmaceuticals, Inc.
China Renaissance Capital Investment II GPSagent Pharmaceuticals, Inc.
China Renaissance Capital Investment II, L.P.Sagent Pharmaceuticals, Inc.
Drake LorinSagent Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

FEKETE MICHAELSagent Pharmaceuticals, Inc.

FLANAGAN ROBERT JSagent Pharmaceuticals, Inc.

Greve Jeffrey W.Sagent Pharmaceuticals, Inc.

Harmon J FrankSagent Pharmaceuticals, Inc.

HUSSEY JAMES MSagent Pharmaceuticals, Inc.

Jonathon M SingerSagent Pharmaceuticals, Inc.

Key Gate Investments LtdSagent Pharmaceuticals, Inc.

Krizman AnthonySagent Pharmaceuticals, Inc.

KUNG FRANKSagent Pharmaceuticals, Inc.

Logerfo MichaelSagent Pharmaceuticals, Inc.

MORGAN STANLEY AIP GP LPSagent Pharmaceuticals, Inc.

MORGAN STANLEY INVESTMENT MANAGEMENT INCSagent Pharmaceuticals, Inc.

OBERMAN ALLANSagent Pharmaceuticals, Inc.

Patterson AlbertSagent Pharmaceuticals, Inc.

Pauli RonaldSagent Pharmaceuticals, Inc.

SHEA THOMAS JOSEPHSagent Pharmaceuticals, Inc.

Sperans JamesSagent Pharmaceuticals, Inc.

Vivo Ventures Fund VI, L.P.Sagent Pharmaceuticals, Inc.

Vivo Ventures Fund V, L.P.Sagent Pharmaceuticals, Inc.

Vivo Ventures V Affiliates Fund, L.P.Sagent Pharmaceuticals, Inc.

VIVO VENTURES VI AFFIILATES FUND, L.P.Sagent Pharmaceuticals, Inc.

Vivo Ventures VI, LLCSagent Pharmaceuticals, Inc.

Vivo Ventures V, LLCSagent Pharmaceuticals, Inc.

WARD MICHAEL V.Sagent Pharmaceuticals, Inc.

Yanai ShlomoSagent Pharmaceuticals, Inc.

YORDON JEFFREYSagent Pharmaceuticals, Inc.

Yu Chen-MingSagent Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Sagent Pharmaceuticals, Inc.	Feb 24, 2012	AwardD	4,380	0.00 USD	$0	SEC